Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Find out when to change your budget based on your spending habits. Regular adjustments can improve your financial health.
23,632 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A domestic uranium producer is expanding beyond ore to processing key minerals. This article breaks down the strategy...
Mativ's 2025 earnings cycle reveals a company navigating macro headwinds with disciplined execution. This article bre...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
As the clean energy shift accelerates, two hydrogen-focused leaders—Bloom Energy and Plug Power—offer distinct paths ...
Today’s jump in the super micro computer stock surprised many, even as revenue guidance cooled. This article breaks d...
As shipping cycles turn, Safe Bulkers faces a critical earnings season. This guide deconstructs the Q4 2025 call, hig...
When a tech giant pulls back from its peak, it creates both risk and opportunity. This guide breaks down why Meta Pla...
Looking for biotech growth with real upside? This piece breaks down two innovative biotech stocks that could deliver ...
Investors eyeing SpaceX pre-IPO opportunities can gain exposure through established AI leaders. This guide explains h...
Fiserv is a payments and tech-enabled services giant that faced headwinds. This in-depth look breaks down the challen...
Last month, sandisk stock skyrocketed 54.6% as AI-driven sentiment surged. This article breaks down the factors behin...